Matterhorn Biosciences ^Company

Matterhorn Biosciences is a biotechnology company that specializes in developing cellular therapies that target the MR1 molecule. This molecule presents cancer-specific metabolites on the surface of cancer cells that can be recognized and killed by T cells bearing an MR1-specific T cell receptor.